Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for XCUR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.026M
June 30, 2025 0.00
March 31, 2025 0.027M
December 31, 2024 5.213M
September 30, 2024 5.431M
June 30, 2024 5.644M
March 31, 2024 5.843M
December 31, 2023 6.039M
September 30, 2023 6.231M
June 30, 2023 6.419M
March 31, 2023 6.595M
December 31, 2022 6.767M
September 30, 2022 6.935M
June 30, 2022 7.101M
March 31, 2022 7.254M
Date Value
December 31, 2021 14.28M
September 30, 2021 24.35M
June 30, 2021 24.43M
March 31, 2021 24.49M
December 31, 2020 24.55M
September 30, 2020 24.59M
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 5.024M
September 30, 2019 5.056M
June 30, 2019 5.085M
March 31, 2019 5.187M
December 31, 2018 4.925M
September 30, 2018 4.926M
June 30, 2018 4.903M
March 31, 2018 4.879M
December 31, 2017 4.855M
September 30, 2017 5.221M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 0.00
Manhattan Scientifics, Inc. --
Century Therapeutics, Inc. 34.63M
Absci Corp. 1.792M
Celularity, Inc. 60.71M